Congressman Greg Murphy, M.D. (NC-03) issued the following statement after voting against H.R. 3. If made law, the legislation would institute price controls on prescription drugs, and implement a 95 percent tax on pharmaceutical companies that do not comply.
"Although the concern over the high cost of prescription drugs is bipartisan, there is still much debate to be had about the best path moving forward. H.R. 3 is a well-intentioned but poorly executed plan to fix the often-unbearable price of prescription drugs in this country," said Murphy.
"As a practicing urologist, I have seen more cures to diseases created in the last five years than the 70 preceding years combined. But by instituting price controls on prescription drugs, this legislation would significantly hamper research and development. There are better ways we can lower drug prices, like reigning in the practices of pharmacy benefit managers and curtailing direct-to-consumer advertising. It's imperative that we refrain from passing legislation that produces unintended consequences precluding scientists from finding the miraculous cures of tomorrow. We owe it to our children and grandchildren."
On Wednesday, Murphy penned an op-ed which was published by The Hill outlining his objections to H.R. 3 and offering his thoughts on alternate solutions. The article can be found HERE
- Michael Mead
- Communications Director
- Congressman Greg Murphy, M.D. (NC-03)
- Ph: (202) 225-3415